Dysregulation of non-heme iron metabolism in glial brain tumors

Medical Principles and Practice

Volumn 14, Issue 4, 2005, Pages 221-229

  Mykhaylyk, Olga ^a,c   Dudchenko, Nataly ^a   Cherchenko, Ada ^b   Rozumenko, Volodymir ^b   Zozulya, Yuriy ^b  

^a Department of Quantum Electronics   (Ukraine)

^b Institute of Neurosurgery Ams of Ukraine   (Ukraine)

^c Institut für Experimentelle Onkologie und Therapieforschung   (Germany)

Author keywords

Chelatable iron; Electron spin resonance; Experimental models in rats; Glial brain tumors; Patients; Stored iron; Transferrin iron

Indexed keywords

IRON; TRANSFERRIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BRAIN BIOPSY; BRAIN CORTEX; BRAIN REGION; BRAIN TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON ENERGY LOSS SPECTROSCOPY; EXPERIMENTAL NEOPLASM; FEMALE; GLIA CELL; HUMAN; IRON BLOOD LEVEL; IRON CHELATION; IRON METABOLISM; IRON TRANSPORT; MALE; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; RAT; STATISTICAL SIGNIFICANCE; TISSUE SECTION;

ADULT; ANIMALS; BRAIN NEOPLASMS; ELECTRON SPIN RESONANCE SPECTROSCOPY; FEMALE; GLIOBLASTOMA; HUMANS; IRON; IRON CHELATING AGENTS; LIVER; MALE; MIDDLE AGED; MODELS, ANIMAL; RATS; RECEPTORS, TRANSFERRIN; TRANSFERRIN;

EID: 20944435455     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085739     Document Type: Article

References (43)

1. Bird CL, Witte JS, Swendseid ME, Shikany JM, Hunt IF, Frankl HD, Lee ER, Longnecker MP, Halle RW: Plasma ferritin, iron intake, and the risk of colorectal polyps. Am J Epidemiol 1996;144:34-41.
2. Herrinton LJ, Friedman GD, Baer D, Selby JV: Transferrin saturation and risk of cancer. Am J Epidemiol 1995;142:692-698.
3. Hsing AW, McLaughlin JK, Olsen JH, Mellemkjar L, Wacholder S, Fraumeni JF Jr: Cancer risk following primary hemochromatosis: A population-based cohort study in Denmark. Int J Cancer 1995;60:160-162.
4. Nelson RL, Davis FG, Persky V, Becker E: Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis. Cancer 1995;76:875-879.
5. Kovar J, Stunz LL, Stewart BC, Kriegerbeckova K, Ashman RF, Kemp JD: Direct evidence that iron deprivation induces apoptosis in murine lymphoma 38C13. Pathobiology 1997;65:61-68.
6. Weinberg ED: Iron withholding: A defence against infection and neoplasia. Physiol Rev 1984;64:65-102.
7. Hughes NR: Serum transferrin and ceruloplasmin concentrations in patients with carcinoma, melanoma, sarcoma and cancers of haematopoietic tissues. Aust J Exp Biol Med Sci 1972;50:97-107.
8. Okada S: Iron-induced tissue damage and cancer: The role of reactive oxygen species-free radicals. Pathol Int 1996;46:311-332.
9. Brodie C, Siriwardana G, Lucas J, Schleicher R, Terada N, Szepesi A, Gelfand E, Seligman P: Neuroblastoma sensitivity to growth inhibition by deferrioxamine: Evidence for a block in G1 phase of the cell cycle. Cancer Res 1993;53:3968-3975.
10. Link G, Saada A, Pinson A, Konijn AM, Hershko C: Mitochondrial respiratory enzymes are a major target of iron toxicity in rat heart cells. J Lab Clin Med 1998;131:466-474.
11. Evans PH: Free radicals in brain metabolism and pathology. Br Med Bull 1993;49:577-587.
12. Hazard JT, Drysdale JW: Ferritinaemia in cancer. Nature 1977;265:755-756.
13. Sandell EB: Colorimetric Determination of Traces of Metals. New York, Interscience, 1965, vol 3.
14. Dudchenko N, Mychaylyk O: Transferrin iron concentration and transferrin saturation in the whole blood. Biochemistry (Ukraine) 2000;72:43-50.
15. Kozlov AV, Yegorov DYu, Vladmirov YA, Azizova OA: Intracellular free iron in liver tissue and liver homogenate: Studies with electron-paramagnetic resonance on the formation of paramagnetic complexes with desferal and nitric oxide. Free Radic Biol Med 1992;13:9-16.
16. Dudchenko N, Mykhaylyk O: Quantification of chelatable iron in biological tissues using ESR technique on complexation with desferrioxamine B. Biochemistry (Ukraine) 1999;71:122-127.
17. Mykhaylyk OM, Razumov ON, Dudchenko AK, Pankratov YuV, Dobrinsky EK, Sosnitsky VN, Bakai EA: Use of ESR, Mossbauer spectroscopy and SQUID-magnetometry for the characterization of magnetic nanoparticles on the base of metal iron and its implications in vivo; in Hafeli U, et al (eds): Scientific and Clinical Applications of Magnetic Carriers. New York, Plenum Press, 1997, pp 277-298.
18. Mykhaylyk OM, Dudchenko NA: Non-heme iron determination in biological samples on evidence derived from electron spin resonance data; in Collery Ph et al (eds): Metal Ions in Biology and Medicine. Paris, John Libbey Eurotext, 1998, vol 5, pp 3-7.
19. Mykhaylyk O, Török G, Dudchenko O, Stavinska O, Dudchenko N, Steinberg F: On the magnetic ordering of the iron storage proteins in tissues. J Magn Magn Mater 2004;272-276P3:2422-2423.
20. Peisach J, Blumberg WE, Wittenberg BA, Wittenberg JB, Kampa L: Hemoglobin A: An electron paramagnetic resonance study of the effects of interchain contacts on the heme symmetry of high-spin and low-spin derivatives of ferric alpha chains. Proc Natl Acad Sci USA 1969;63:934-939.
21. Weil JA, Bolton JR, Wertz JE: Electron paramagnetic resonance - elementary theory and practical applications. New York, Wiley, 1994, 568 pp.
22. Bradbury MW: Transport of iron in the blood-brain-cerebrospinal fluid system. J Neurochem 1997;69:443-454.
23. Suh YJ, Samuel D: Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem 2003;278:27144-27148.
24. Lis A, Barone TA, Paradkar PN, Plunkett RJ, Roth JA: Expression and localization of different forms of DMT1 in normal and tumor astroglial cells. Brain Res Mol Brain Res 2004;122:62-70.
25. Hann HW, Evans AE, Cohen IJ, Leitmeyer JE: Biologic differences between neuroblastoma stages IV-S and IV: Measurement of serum ferritin and E-rosette inhibition in 30 children. N Engl J Med 1981;305:425-429.
26. Kifle Y, Monnier J, Chesrown SE, Raizada MK, Nick HS: Regulation of the manganese superoxide dismutase and inducible nitric oxide synthase gene in rat neuronal and glial cells. J Neurochem 1996;66:2128-2135.
27. Matzner Y, Hershko C, Polliack A, Konijn AM, Izak G: Suppressive effect of ferritin on in vitro lymphocyte function. Br J Haematol 1979;42:345-353.
28. Eisenstein RS, Garcia-Mayol D, Pettingell W, Munro HN: Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron. Proc Natl Acad Sci USA 1991;88:688-692.
29. Schipper HM: Heme oxygenase-1: Transducer of pathological brain iron sequestration under oxidative stress. Ann NY Acad Sci 2004;1012:84-93.
30. Watts RN, Ponka P, Richardson DR: Effects of nitrogen monoxide and carbon monoxide on molecular and cellular iron metabolism: Mirror-image effector molecules that target iron. Biochem J 2003;369:429-440.
31. Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A, Ahlbom A, Choi WN, Giles GG, Howe GR, Little J, Menegoz F, Ryan P: Role of medical history in brain tumour development: Results from the international adult brain tumour study. Int J Cancer 1999;82:155-160.
32. Lote K, Stenwig AE, Skullerud K, Hirschberg H: Prevalence and prognostic significance of epilepsy in patients with gliomas. Eur J Cancer 1998;34:98-102.
33. Penfield W, Erickson TC, Tarlov I: Relation of intracranial tumors and symptomatic epilepsy. Arch Neurol Psychiatry 1940;44:300-315.
34. Willmore LJ: Post-traumatic epilepsy: Cellular mechanisms and implications for treatment. Epilepsia 1990;31(suppl 3):S67-S73.
35. Willmore LJ, Sypert GW, Munson JB, Hurd RW: Chronic focal epileptiform discharges induced by injection of iron into rat and cat cortex. Science 1978;200:1501-1503.
36. Willmore LJ, Rubin JJ: Antiperoxidant pretreatment and iron-induced epileptiform discharges in the rat: EEG and histopathologic studies. Neurology 1981;31:63-69.
37. Wen WN: Methemoglobin contributes to the growth of human tumor cells. Life Sci 2002;70:907-916.
38. Kennett EC, Kuchel PW: Redox reactions and electron transfer across the red cell membrane. IUBMB Life 2003;55:375-385.
39. Lalo UV, Pankratov YV, Mykhaylyk OM: Steady magnetic fields effect on lipid peroxidation kinetics. Redox Rep 1994;1:71-75.
40. 2+, and functional alterations in lymphocytes and macrophages after in vitro exposure to static magnetic field. J Toxicol Environ Health 1998;54:63-76.
41. Hann HW, Levy HM, Evans AE: Serum ferritin as a guide to therapy in neuroblastoma. Cancer Res 1980;40:1411-1413.
42. Iancu TC, Shiloh H, Kedar A: Neuroblastomas contain iron-rich ferritin. Cancer 1988;61:2497-2502.
43. Estrov Z, Tawa A, Wang XH, Dube ID, Sulh H, Cohen A, Gelfand EW, Freedman MH: In vitro and in vivo effects of deferoxamine in neonatal acute leukemia. Blood 1987;69:757-761.